Source: Reuters

Researchers at Harvard’s Wyss Institute are developing microchips comprising the cells and functionality of human organs.

These organs-on-a-chip represent an advance that could prove revolutionary for pharmaceutical companies who spend billions of dollars testing new drugs in controversial – and often ineffective – animal trials. Ben Gruber reports.

http://www.reuters.com/resources_v2/flash/video_embed.swf?videoId=235912541&edition=BETAUS